Category Archives: Uncategorized

Is COVID a Plandemic 2?

In the public interest.

Is the Johns Hopkins/Gates Foundation funded World Economic Forum Event 201 Coronavirus simulation to prepare for a pandemic, a coincidence or a planning meeting?

Are they collapsing our governments using a bioweapon or is it just a virus that occurred.

The world is waking up to the real misinformation. Truth is carried on the winds of humanities rise for freedom as we break the chains that we know recognise held us down for centuries. Greed is the illusion.

Does truth matter? What is the real power of this world.

Zoom Information Data Collection Goes to Whom?

In the public interest.

I won’t go on zoom. I am finding overtime I will move away from online technology as it is not private and the data is gathered. This is what happens when corruption penetrates government.

When greed and narcissistic personality disorder become normal the criminality escalates without accountability.

The privatisation of intelligence for commercial sale is a danger to citizens.

What is a leader? What is sovereignty? What is trust? What is fairness?

Vaccine Manufacturers SHOULD NOT be Indemnified from Prosecution

This gives the green light for more deaths in my view.  How can you indemnify a manufacturer of vaccines when it is a trial?  How can you allow them to use the public as guinea pigs?  This is a risk to people.  I am concerned that the public will be harmed by the vaccine.

I Susan Carew will not be taking any vaccine that is not safe. I regard no indemnity as not safe for myself and I as a sovereign person it is my body and I am not unwell.  I will not be taking it.  I have seen the research on vaccine injury, autism and I do not feel safe.

Indemnity granted for COVID-19 vaccine side effects

Indemnity granted for COVID-19 vaccine side effects

The Morrison government has given the suppliers of two COVID-19 vaccines indemnity against prosecution for side effects that experts say are “inevitable” when a vaccine is rolled out.

The government will not set up a statutory compensation scheme, meaning Australians who suffered ‘extremely rare’ side effects would face a tough ba

9 comments

As part of its $1.7 billion deals to secure more than 84.8 million doses of vaccines, the federal government has indemnified the suppliers – meaning they cannot be held liable for adverse events caused by the vaccines.

Plans to distribute the vaccine quickly across the population once successful phase three trials are complete mean the full safety picture will not be known when the first doses are administered.

British pharmaceutical company AstraZeneca is the sponsor of the Oxford University vaccine, while the University of Queensland vaccine is being marketed by Seqirus (CSL).

By MSN News […]

The Morrison government has given the suppliers of two COVID-19 vaccines indemnity against prosecution for rare side effects that experts say are “inevitable” when a vaccine is rolled out to 25 million Australians.

But the government will not set up a statutory compensation scheme which the president of the Australian Medical Association, Omar Khorshid, said meant Australians who suffered “extremely rare” side effects from the vaccines would face a tough battle to seek compensation.

“With a brand new vaccine, it’s going to be really hard to tell what is a vaccine injury and what is a rare medical condition that someone would have had anyway,” Dr Khorshid said.

As part of its $1.7 billion deals to secure more than 84.8 million doses of the Oxford University and University of Queensland vaccines if successful, the federal government has indemnified the suppliers – meaning they cannot be held liable for adverse events caused by the vaccines.

British pharmaceutical company AstraZeneca is the sponsor of the Oxford University vaccine, while the University of Queensland vaccine is being marketed by Seqirus (CSL).

Plans to distribute the vaccine quickly across the population once successful phase three trials are complete mean the full safety picture will not be known when the first doses are administered.

Government promises swift action after Aged Care RC pandemic findings

Tuesday’s federal budget assumed a nation-wide vaccination program would be rolled out next year.

But the government has rejected calls to set up a no-fault vaccine injury compensation scheme, instead opting to pick up the bill for any compensation payout if a member of the public takes legal action against the drug companies.

University of Sydney Associate Professor Nick Wood, a vaccine expert who designs hospital immunisation programs, said Australians who received a COVID-19 vaccine “for the benefit of themselves and the community” deserved the reassurance of a “safety net” through a no-fault scheme in case they experienced a rare adverse reaction.

Grattan Institute health economist Stephen Duckett, a former secretary of the federal health department, agreed that such a scheme was needed, saying there would “inevitably” be some adverse events associated with the vaccines and that some may take years to appear.

No-fault vaccine injury compensation schemes allow people who experience an adverse reaction to access compensation without having to convince a court that the vaccine was the cause of their injury.

Dr Duckett said safety data would continue to be collected after a COVID-19 vaccine was rolled out, giving a clearer picture over time of any adverse events, including by people in vulnerable groups such as diabetics and people with blood pressure conditions.

Professor Wood said community confidence would be vital in ensuring that there was wide enough take-up of the vaccine for it to be effective at preventing COVID-19 from spreading.

“If we get a scare and someone has a reaction, coverage will probably be hard to get up,” he said.

The no-fault schemes operate in Canada, New Zealand, the United States, the United Kingdom, Austria, Denmark, Finland, France, Germany, Hungary, Iceland, Italy, Norway, Russia, Latvia, Slovenia, Sweden, Switzerland, China, Japan, South Korea, Vietnam, Nepal and Thailand.

A spokesman for the federal health department said the government was “committed to providing access to safe and effective COVID-19 vaccines” and had agreed to indemnify the drug companies due to “the need to appropriately share risks associated with achieving early access to a successful vaccine.”

ARDA, DARPA, AstraZeneca and COVID-19

ARDA, DARPA support AstraZeneca through phase 1 trial of COVID-19 therapeutic

© Shutterstock

The Biomedical Advanced Research and Development Authority (BARDA) and the Defense Advanced Research Projects Agency (DARPA) have reached an interagency agreement with AstraZeneca to support phase 1 clinical development of a monoclonal antibody combination therapy for use against COVID-19.

This assistance will cover both a phase 1 clinical trial and the manufacturing of the investigational product for testing. AstraZeneca, which recently signed a deal granting it an exclusive license for six anti-SARS-CoV-2 antibodies identified by researchers at Vanderbilt University, intends to start a phase 1 trial of a COVID-19 antibody therapy within two months.

The body generates antibodies to fight off infections. Monoclonal antibodies, like those used in this case, are laboratory synthesized therapies that can be manufactured in large quantities and used to negate viruses. A combination of such antibodies targeting the SARS-CoV-2 virus — the virus that causes COVID-19 — could conceivably be used to both prevent infection and to treat existing infections.

This is not a treatment approved by the U.S. Food and Drug Administration (FDA), though. There remain no FDA-approved treatments or vaccines for COVID-19, a fact that has spurred the Department of Health and Human Services to label the need for therapeutic and prophylactic antibody therapies urgent.